Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0001231919-26-000852

Director bought 312,500 shares at $16.00 ($5,000,000)

  • Director acquired 3,301,534 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chen Bihua Director 2026-08-10 Conversion +1,599,993 1,599,993 I: show line 1 in the form
Chen Bihua Director 2026-08-10 Conversion +1,701,541 3,301,534 I: show line 2 in the form
Chen Bihua Director 2026-08-10 Purchase +312,500 $16.00 $5,000,000 3,614,034 I: show line 3 in the form
Open-market purchases · 312,500 sh · avg $16.00 · $5,000,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Chen Bihua Director 2026-08-06 Grant or award · Director Stock Option (Right to Buy) +23,904 23,904 D: show line 4 in the form
Chen Bihua Director 2026-08-10 Conversion · Series A Preferred Stock −1,599,993 0 I: show line 5 in the form
Chen Bihua Director 2026-08-10 Conversion · Series B Preferred Stock −1,701,541 0 I: show line 6 in the form
Loading xslF345X06/form4-08102026_100859.xml…